Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (5y) (2016 - 2021)

Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (5y) (2016 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn -
2 Nanobiotix 1,899.87 Bn 1,899.81 Bn -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn -
4 BeOne Medicines 470.43 Bn 465.64 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.43 Bn 116.19 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.20 Bn 61.44 Bn 3.31 Bn
7 Belite Bio 61.75 Bn 61.75 Bn -
8 Argenx Se 56.15 Bn 50.96 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn
10 Oramed Pharmaceuticals 167.23 Mn 167.23 Mn -

Historic Data

Download Data
DateValue
Aug 31, 2021 459.00
Aug 31, 2019 252.00
May 31, 2019 -7,662.00
Feb 28, 2019 -6,769.00
Nov 30, 2018 -8,781.00
Aug 31, 2018 -10,589.00
May 31, 2018 4,311.00
Feb 28, 2018 2,774.00
Nov 30, 2017 2,329.00
Aug 31, 2017 5,741.00
May 31, 2017 3,544.00
Feb 28, 2017 3,581.00
Nov 30, 2016 1,460.00